NVAX - Novavax Inc.

NVAX valuation $1.86 billion

Stock Price

7.81
Change: ↓ -0.05 (-0.636132%)
Last Update: 2015-01-30T16:16:47-05:00
Shares Outstanding: 238,477,974
Industry: Biotechnology

Novavax, Inc. (NASDAQ:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide.

Using innovative proprietary recombinant nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases.

Stock Price Data

Open: 7.82 Previous Close: 7.86
High: 8.07 Low: 7.74
Bid: 7.81 Ask: 7.85

Bid Size: 1700 Ask Size: 200
Raw Bid Size: 17 Raw Ask Size: 2
Trade Volume: 17534 Share Volume: 4764740
Last Trade Date: 2015-01-30 Last Trade Time: 16:14:56-05:00
Vwap: 7.88109952 EPS: -0.30

Fundamental Data

PE ratio: PB ratio: 7.10
Beta: 1.243648

52 Week High: 8.06 52 Week Low: 3.34
52 Week High Vwap: 7.7929 52 Week Low Vwap: 3.5344
52 Week High Volume: 40464005 52 Week Low Volume: 949284
52 Week Avg Volume: 4213986
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29